Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1Gynecologic 1Genitourinary 1

Conditions

Ovarian Neoplasms 5Ovarian Germ Cell Cancer 5Testicular Neoplasms 4Teratoma 4Vulvar Neoplasms 3Uterine Cervical Neoplasms 1Sertoli-Leydig Cell Tumor 1Ovarian gynandroblastoma 1Granulosa cell tumor of the ovary 1Endodermal Sinus Tumor 1Drug-Related Side Effects and Adverse Reactions 1Central Nervous System Neoplasms 1

Interventions

Paclitaxel 8Filgrastim 8Carboplatin 8Peripheral Blood Stem Cell Transplantation 6Ifosfamide 6Etoposide 4Temozolomide 3pembrolizumab 2pegfilgrastim 2ixabepilone 2etoposide phosphate 2Thiotepa 2Melphalan 2Gemcitabine 2Cisplatin 2Amifostine 2sodium thiosulfate 1regorafenib 1carboxyamido-triazole 1aflibercept 1Trabectedin 1Topotecan 1Taxes 1Surveys and Questionnaires 1Restraint, Physical 1Radiotherapy 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1PT-100 dipeptide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Bleomycin × Gynecologic × Clear all
NCT00276718 2013-09-17

Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors

National Cancer Institute (NCI)

Phase NA Unknown
100 enrolled
CNSGenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡